Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04189094
What this trial is testing

Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Zhejiang Cancer Hospital 140
Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60
Testing effectiveness (Phase 2)UnknownNCT05790200
What this trial is testing

Cadonilimab (AK104) in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Post-approval studies (Phase 4)Looking for participantsNCT06311942
What this trial is testing

Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

Who this might be right for
HCC
Chen Xiaoping 300
Early research (Phase 1)WithdrawnNCT05393635
What this trial is testing

ITIL-168 in Advanced Solid Tumors

Who this might be right for
Cervical CancerHead and Neck Squamous Cell CarcinomaNon-small Cell Lung Cancer
Instil Bio
Testing effectiveness (Phase 2)Looking for participantsNCT06817525
What this trial is testing

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 64
Testing effectiveness (Phase 2)UnknownNCT05048017
What this trial is testing

Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRegorafenibPD-1 Inhibitor
Peking Union Medical College Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT05862064
What this trial is testing

A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 606
Testing effectiveness (Phase 2)Looking for participantsNCT06132698
What this trial is testing

Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC

Who this might be right for
NSCLC Associated With Leptomeningeal Metastases
West China Hospital 17
Testing effectiveness (Phase 2)Ended earlyNCT04549025
What this trial is testing

Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen

Who this might be right for
NSCLC
Jounce Therapeutics, Inc. 69
Testing effectiveness (Phase 2)UnknownNCT06186609
What this trial is testing

PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Affiliated Hospital of Nantong University 68
Not applicableUnknownNCT06402981
What this trial is testing

A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

Who this might be right for
Immune Checkpoint InhibitorsLiver Injury
Zhejiang University 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT03259867
What this trial is testing

Combination of TATE and PD-1 Inhibitor in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaGastric Cancer
Teclison Ltd. 54
Not applicableLooking for participantsNCT06475807
What this trial is testing

Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Cancer
University of Pittsburgh 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05366166
What this trial is testing

Pembrolizumab Plus Olaparib in LA-HNSCC

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
UNC Lineberger Comprehensive Cancer Center 45
Not applicableNot Yet RecruitingNCT07573397
What this trial is testing

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Fudan University 88
Not applicableLooking for participantsNCT06671613
What this trial is testing

Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer

Who this might be right for
Stage IV NSCLCNSCLCImmunotherapy+1 more
VA Office of Research and Development 66
Testing effectiveness (Phase 2)Looking for participantsNCT06455124
What this trial is testing

Short-course Radiotherapy Combined With CapeOx and PD-1 Inhibitor After Local Excision for High-risk Early Rectal Cancer (TORCH-LE)

Who this might be right for
Rectal Cancer
Fudan University 60
Early research (Phase 1)Study completedNCT05303090
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 56
Testing effectiveness (Phase 2)Looking for participantsNCT07126119
What this trial is testing

Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC

Who this might be right for
Upper Tract Urothelial CarcinomaNeoadjuvant TherapyPD-1 Inhibitor+1 more
Tianjin Medical University Second Hospital 35
Next Page